Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7376)
All Articles published online
|
Publishing Process of This Article
|
Feb 28, 2017 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Guo JH, Zhang HY, Gao S, Zhang PJ, Li XT, Chen H, Wang XD, Zhu X. Hepatic artery infusion with raltitrexed or 5-fluorouracil for colorectal cancer liver metastasis. World J Gastroenterol 2017; 23(8): 1406-1411 [PMID: 28293087 DOI: 10.3748/wjg.v23.i8.1406] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i8/1406.htm |
| Number | Citing Articles |
| 1 |
Nicolas Chapelle, Tamara Matysiak-Budnik, Frédéric Douane, Sylvie Metairie, Philippe Rougier, Yann Touchefeu. Hepatic arterial infusion in the management of colorectal cancer liver metastasis: Current and future perspectives. Digestive and Liver Disease 2018; 50(3): 220 doi: 10.1016/j.dld.2017.12.004
|
| 2 |
Francois Ghiringhelli, Julie Vincent, Leila Bengrine, Christophe Borg, Jean Louis Jouve, Romaric Loffroy, Boris Guiu, Julie Blanc, Aurélie Bertaut. Hepatic arterial chemotherapy with raltitrexed and oxaliplatin versus standard chemotherapy in unresectable liver metastases from colorectal cancer after conventional chemotherapy failure (HEARTO): a randomized phase-II study. Journal of Cancer Research and Clinical Oncology 2019; 145(9): 2357 doi: 10.1007/s00432-019-02970-8
|
| 3 |
Chunhou Qi, Hongfei Gao, Shankai Li, Huanbo Zong, Hongjun Hao, Lei Zhang. A Case–Control Study on the Correlation Between Thymidylate Synthase Gene Polymorphisms and Raltitrexed Treatment Combined with Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Treatment. Genetic Testing and Molecular Biomarkers 2020; 24(3): 156 doi: 10.1089/gtmb.2019.0111
|
| 4 |
Ai-Wei Feng, Jian-Hai Guo, Song Gao, Fu-Xin Kou, Shao-Xing Liu, Peng Liu, Hui Chen, Xiao-Dong Wang, Hai-Feng Xu, Guang Cao, Xu Zhu. A randomized phase II trial of hepatic arterial infusion of oxaliplatin plus raltitrexed versus oxaliplatin plus 5-fluorouracil for unresectable colorectal cancer liver metastases. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.913017
|
| 5 |
Erica M. Knavel Koepsel, Amanda R. Smolock, Jason W. Pinchot, Charles Y. Kim, Osmanuddin Ahmed, Murthy R.K. Chamarthy, Elizabeth M. Hecht, Gloria L. Hwang, David E. Kaplan, Join Y. Luh, Jorge A. Marrero, Eric J. Monroe, George A. Poultsides, Matthew J. Scheidt, Eric J. Hohenwalter. ACR Appropriateness Criteria® Management of Liver Cancer: 2022 Update. Journal of the American College of Radiology 2022; 19(11): S390 doi: 10.1016/j.jacr.2022.09.005
|
| 6 |
Jiahui He, Hang Sun, Fei Li, Hao Yang, Minggeng Lou, Shunde Wang, Chuanxin Wu. Efficacy and safety of raltitrexed‐based transcatheter arterial chemoembolization for intermediate and advanced hepatocellular carcinoma: A multicenter real‐world study. Hepatology Research 2021; 51(11): 1153 doi: 10.1111/hepr.13708
|
| 7 |
Ragaa A Ramadan, Thanaa F Moghazy, Radwa Hafez, Heba Morsi, Mohamed Samir, Mohamed Shamesya. Significance of expression of pyrimidine metabolizing genes in colon cancer. Arab Journal of Gastroenterology 2020; 21(3): 189 doi: 10.1016/j.ajg.2020.07.006
|
| 8 |
Guoliang Shao, Ruibao Liu, Wenbin Ding, Ligong Lu, Wentao Li, Huicun Cao, Rong Liu, Caixia Li, Hua Xiang, Zhengqiang Yang, Jijin Yang, Jinlong Song, Jianhua Wang. Efficacy and safety of raltitrexed-based transarterial chemoembolization for colorectal cancer liver metastases. Anti-Cancer Drugs 2018; 29(10): 1021 doi: 10.1097/CAD.0000000000000690
|
| 9 |
N. Wei, B. Zhang, Y. Wang, X. H. He, L. C. Xu, G. D. Li, Y. H. Wang, G. Z. Wang, H. Z. Huang, W. T. Li. Transarterial chemoembolization with raltitrexed-based or floxuridine-based chemotherapy for unresectable colorectal cancer liver metastasis. Clinical and Translational Oncology 2019; 21(4): 443 doi: 10.1007/s12094-018-1942-0
|
| 10 |
Stefano Guadagni, Marco Clementi, Andrew R. Mackay, Enrico Ricevuto, Giammaria Fiorentini, Donatella Sarti, Paola Palumbo, Panagiotis Apostolou, Ioannis Papasotiriou, Francesco Masedu, Marco Valenti, Aldo Victor Giordano, Gemma Bruera. Real-life multidisciplinary treatment for unresectable colorectal cancer liver metastases including hepatic artery infusion with chemo-filtration and liquid biopsy precision oncotherapy: observational cohort study. Journal of Cancer Research and Clinical Oncology 2020; 146(5): 1273 doi: 10.1007/s00432-020-03156-3
|
| 11 |
Claire Gallois, Emilie Hafliger, Edouard Auclin, Audrey Perret, Clélia Coutzac, Anthony Turpin, Anna Pellat, Violaine Randrian, Debora Basile, Roger Faroux, Simon Pernot, Christophe Locher, Vincent Hautefeuille, Olivier Dubreuil, Lola-Jade Palmieri, Marie Dior, Pascal Artru, Julien Taieb. First-line chemotherapy with raltitrexed in metastatic colorectal cancer: an Association des Gastro-entérologues Oncologues (AGEO) multicentre study. Digestive and Liver Disease 2022; 54(5): 684 doi: 10.1016/j.dld.2021.08.009
|
| 12 |
Baojiang Liu, Xu Zhu, Song Gao, Jianhai Guo, Xiaodong Wang, Guang Cao, Linzhong Zhu, Peng Liu, Haifeng Xu, Hui Chen, Xin Zhang, Shaoxing Liu, Fuxin Kou. Safety and efficacy of hepatic arterial infusion chemotherapy with raltitrexed and oxaliplatin post-transarterial chemoembolization for unresectable hepatocellular carcinoma. Journal of Interventional Medicine 2019; 2(2): 91 doi: 10.1016/j.jimed.2019.07.006
|
| 13 |
Yueqi Li, Yiyang Chen, Cen Qiu, Xiaoying Ma, Kecheng Lei, Guoxiang Cai, Xin Liang, Jianwen Liu. 17‐allylamino‐17‐demethoxygeldanamycin impeded chemotherapy through antioxidant activation via reducing reactive oxygen species‐induced cell death. Journal of Cellular Biochemistry 2019; 120(2): 1560 doi: 10.1002/jcb.27397
|
| 14 |
Linzhong Zhu, Nan Zheng, Xingang Li, Xiaofeng Zhang. Hepatic Artery and Peripheral Vein Pharmacokinetics of Raltitrexed in Swine After the Administration of a Hepatic Arterial Infusion. Current Drug Metabolism 2019; 20(7): 601 doi: 10.2174/1389200220666190618100847
|
| 15 |
宇 郭. Progress in the Treatment of Hepatocellular Carcinoma Based on Hepatic Arterial Infusion Chemotherapy. Advances in Clinical Medicine 2022; 12(01): 587 doi: 10.12677/ACM.2022.121087
|
| 16 |
欣鑫 涂. Efficacy of Raltitrexed in Digestive System Tumors. Advances in Clinical Medicine 2023; 13(04): 6544 doi: 10.12677/ACM.2023.134917
|
| 17 |
|
| 18 |
B. Sree Ganesh, Mufaddal Kazi, Mahesh Goel, Avanish Saklani, Ashwin De Souza, Sanjana Devarmani, Kunal Gala, Nitin Shetty, Suyash Kulkarni, Anant Ramaswamy, Vikas Ostwal, Prabhat Bhargava, Shraddha Patkar. Feasibility of Hepatic Artery Infusion Chemotherapy for Colorectal Liver Metastasis in an Indian Setting. Indian Journal of Surgical Oncology 2023; doi: 10.1007/s13193-023-01871-0
|
| 19 |
Qianyi Gong, Changfeng Song, Xiaotong Wang, Renjie Wang, Guoxiang Cai, Xin Liang, Jianwen Liu. Hyperthermic intraperitoneal chemotherapy with recombinant mutant human TNF-α and raltitrexed in mice with colorectal-peritoneal carcinomatosis. Experimental Biology and Medicine 2020; 245(6): 542 doi: 10.1177/1535370220905047
|
| 20 |
Yonghua Bi, Dechao Jiao, Yang Wang, Xinwei Han, Jianzhuang Ren. Preliminary outcomes of raltitrexed eluting bead-transarterial chemoembolization using Callispheres® beads for gastrointestinal adenocarcinoma liver metastasis. World Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02696-x
|
| 21 |
Lin-Zhong Zhu, Song Xu, Hai-Long Qian. Transarterial embolization and low-dose continuous hepatic arterial infusion chemotherapy with oxaliplatin and raltitrexed for hepatocellular carcinoma with major portal vein tumor thrombus. World Journal of Gastroenterology 2018; 24(23): 2501-2507 doi: 10.3748/wjg.v24.i23.2501
|